Morgan Stanley Cortexyme, Inc. Transaction History
Morgan Stanley
- $1.35 Trillion
- Q3 2024
A detailed history of Morgan Stanley transactions in Cortexyme, Inc. stock. As of the latest transaction made, Morgan Stanley holds 8,522 shares of CRTX stock, worth $10,993. This represents 0.0% of its overall portfolio holdings.
Number of Shares
8,522
Previous 8,522
-0.0%
Holding current value
$10,993
Previous $10,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
18 transactions
Others Institutions Holding CRTX
# of Institutions
39Shares Held
5.21MCall Options Held
90.8KPut Options Held
0-
Vanguard Group Inc Valley Forge, PA1.2MShares$1.55 Million0.0% of portfolio
-
Epiq Capital Group, LLC San Francisco, CA826KShares$1.07 Million0.32% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny523KShares$674,1230.0% of portfolio
-
Almitas Capital LLC Santa Monica, CA383KShares$493,9170.23% of portfolio
-
Black Rock Inc. New York, NY355KShares$457,6760.0% of portfolio
About Cortexyme, Inc.
- Ticker CRTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 36,150,800
- Market Cap $70.5M